_id
69148d4cccc777a4e85d9a98
Ticker
PHRRF
Name
Pharmather Holdings Ltd
Exchange
OTCQB
Address
82 Richmond Street East, Toronto, ON, Canada, M5C 1P1
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.pharmather.com
Description
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX wearable pump for the maintenance of general anesthesia for diagnostic, surgical procedures and pain indications. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson's disease; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.
Last Close
0.074
Volume
34000
Current Price
0.0667
Change
0.002
Last Updated
2026-01-06T09:11:03.443Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
6735411
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-08-31
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
335380
Operating Income
-335380
Interest Expense
-
Pretax Income
-439193
Net Income
-439193
Eps
-0.004825285779413357
Dividends Per Share
-
Shares Outstanding
91019065
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-103818
Cash
939960
Short Term Investments
100000
Receivables
20335
Inventories
-
Total Current Assets
1060295
Property Plant Equipment
-
Total Assets
1257209
Payables
470797
Short Term Debt
-
Long Term Debt
-
Total Liabilities
472858
Equity
784351
Bs_currency_symbol
CAD
Depreciation
-
Change In Working Capital
102163
Cash From Operations
-233253
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
250000
Net Change In Cash
16747
Cf_currency_symbol
CAD
PE
-
PB
7.74012098601264
ROE
-55.994446363936554
ROA
-34.933968815049845
FCF
-233253
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
3
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-08-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
335380
Quarters > 0 > income Statement > operating Income
-335380
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-439193
Quarters > 0 > income Statement > net Income
-439193
Quarters > 0 > income Statement > eps
-0.004825285779413357
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
91019065
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-103818
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
939960
Quarters > 0 > balance Sheet > short Term Investments
100000
Quarters > 0 > balance Sheet > receivables
20335
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1060295
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
1257209
Quarters > 0 > balance Sheet > payables
470797
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
472858
Quarters > 0 > balance Sheet > equity
784351
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-439193
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
102163
Quarters > 0 > cash Flow > cash From Operations
-233253
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
250000
Quarters > 0 > cash Flow > net Change In Cash
16747
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.004825285779413357
Quarters > 0 > ratios > PB
7.74012098601264
Quarters > 0 > ratios > ROE
-55.994446363936554
Quarters > 0 > ratios > ROA
-34.933968815049845
Quarters > 0 > ratios > FCF
-233253
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-02-28
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
357457
Quarters > 1 > income Statement > operating Income
-357457
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-369484
Quarters > 1 > income Statement > net Income
-369484
Quarters > 1 > income Statement > eps
-0.004174061260136446
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
88519065
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-23122
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
1225242
Quarters > 1 > balance Sheet > short Term Investments
66667
Quarters > 1 > balance Sheet > receivables
15968
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1307877
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
1519839
Quarters > 1 > balance Sheet > payables
298164
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
300266
Quarters > 1 > balance Sheet > equity
1219573
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-369484
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
85058
Quarters > 1 > cash Flow > cash From Operations
-261304
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-261304
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.004174061260136446
Quarters > 1 > ratios > PB
4.841220357862956
Quarters > 1 > ratios > ROE
-30.296177432593215
Quarters > 1 > ratios > ROA
-24.31073291315725
Quarters > 1 > ratios > FCF
-261304
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2024-11-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
346293
Quarters > 2 > income Statement > operating Income
-346293
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-367674
Quarters > 2 > income Statement > net Income
-367674
Quarters > 2 > income Statement > eps
-0.0041536136876276315
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
88519065
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-40216
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
1486546
Quarters > 2 > balance Sheet > short Term Investments
66667
Quarters > 2 > balance Sheet > receivables
23579
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1576874
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
1811958
Quarters > 2 > balance Sheet > payables
220799
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
222901
Quarters > 2 > balance Sheet > equity
1589057
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-367674
Quarters > 2 > cash Flow > depreciation
0
Quarters > 2 > cash Flow > change In Working Capital
12454
Quarters > 2 > cash Flow > cash From Operations
-315004
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-315004
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.0041536136876276315
Quarters > 2 > ratios > PB
3.715550565838733
Quarters > 2 > ratios > ROE
-23.137873594213424
Quarters > 2 > ratios > ROA
-20.29152993612435
Quarters > 2 > ratios > FCF
-315004
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-08-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
329137
Quarters > 3 > income Statement > operating Income
-329137
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-380162
Quarters > 3 > income Statement > net Income
-380162
Quarters > 3 > income Statement > eps
-0.0042946906409370685
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
88519065
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-75970
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
1801550
Quarters > 3 > balance Sheet > short Term Investments
100000
Quarters > 3 > balance Sheet > receivables
51309
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1960433
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
2202400
Quarters > 3 > balance Sheet > payables
243623
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
245669
Quarters > 3 > balance Sheet > equity
1956731
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-380162
Quarters > 3 > cash Flow > depreciation
0
Quarters > 3 > cash Flow > change In Working Capital
-27489
Quarters > 3 > cash Flow > cash From Operations
-331681
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-331681
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.0042946906409370685
Quarters > 3 > ratios > PB
3.017390553683669
Quarters > 3 > ratios > ROE
-19.428424244313604
Quarters > 3 > ratios > ROA
-17.261260443152924
Quarters > 3 > ratios > FCF
-331681
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2023-05-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
4014790
Annuals > 0 > income Statement > operating Income
-4014790
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-6416319
Annuals > 0 > income Statement > net Income
-6416319
Annuals > 0 > income Statement > eps
-0.07277290509999171
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
88169065
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-2608349
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
5919808
Annuals > 0 > balance Sheet > short Term Investments
333333
Annuals > 0 > balance Sheet > receivables
55859
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
6309000
Annuals > 0 > balance Sheet > property Plant Equipment
711
Annuals > 0 > balance Sheet > total Assets
6309711
Annuals > 0 > balance Sheet > payables
883890
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
892478
Annuals > 0 > balance Sheet > equity
5417233
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-6416319
Annuals > 0 > cash Flow > depreciation
1422
Annuals > 0 > cash Flow > change In Working Capital
546303
Annuals > 0 > cash Flow > cash From Operations
-3235098
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
0
Annuals > 0 > cash Flow > net Change In Cash
-3235098
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.07277290509999171
Annuals > 0 > ratios > PB
1.2369504763778851
Annuals > 0 > ratios > ROE
-118.44273635636495
Annuals > 0 > ratios > ROA
-101.6895860999022
Annuals > 0 > ratios > FCF
-3235098
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2022-05-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
4102354
Annuals > 1 > income Statement > operating Income
-4102354
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-4235687
Annuals > 1 > income Statement > net Income
-4010636
Annuals > 1 > income Statement > eps
-0.045488017821216545
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
88169065
Annuals > 1 > income Statement > income Tax Expense
-225051
Annuals > 1 > income Statement > EBITDA
-4100577
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-133333
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
9154906
Annuals > 1 > balance Sheet > short Term Investments
2966667
Annuals > 1 > balance Sheet > receivables
30164
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
12161737
Annuals > 1 > balance Sheet > property Plant Equipment
2133
Annuals > 1 > balance Sheet > total Assets
12163870
Annuals > 1 > balance Sheet > payables
323038
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
330318
Annuals > 1 > balance Sheet > equity
11833552
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-4010636
Annuals > 1 > cash Flow > depreciation
1777
Annuals > 1 > cash Flow > change In Working Capital
176451
Annuals > 1 > cash Flow > cash From Operations
-3511040
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
9887865
Annuals > 1 > cash Flow > net Change In Cash
6376825
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.045488017821216545
Annuals > 1 > ratios > PB
0.5662584606887264
Annuals > 1 > ratios > ROE
-33.89207230424137
Annuals > 1 > ratios > ROA
-32.97171048358788
Annuals > 1 > ratios > FCF
-3511040
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2021-05-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
2816833
Annuals > 2 > income Statement > operating Income
-2816833
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
2889247
Annuals > 2 > income Statement > net Income
2664196
Annuals > 2 > income Statement > eps
0.03933271292413442
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
67734865
Annuals > 2 > income Statement > income Tax Expense
225051
Annuals > 2 > income Statement > EBITDA
-2816478
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
5706080
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
2778081
Annuals > 2 > balance Sheet > short Term Investments
3100000
Annuals > 2 > balance Sheet > receivables
28650
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
5940064
Annuals > 2 > balance Sheet > property Plant Equipment
3910
Annuals > 2 > balance Sheet > total Assets
5943974
Annuals > 2 > balance Sheet > payables
129263
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
361060
Annuals > 2 > balance Sheet > equity
5582914
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
2664196
Annuals > 2 > cash Flow > depreciation
355
Annuals > 2 > cash Flow > change In Working Capital
186081
Annuals > 2 > cash Flow > cash From Operations
922190
Annuals > 2 > cash Flow > capital Expenditures
4265
Annuals > 2 > cash Flow > cash From Investing
214769
Annuals > 2 > cash Flow > cash From Financing
1252740
Annuals > 2 > cash Flow > net Change In Cash
2389699
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.03933271292413442
Annuals > 2 > ratios > PB
0.9220721902576324
Annuals > 2 > ratios > ROE
47.72052730885699
Annuals > 2 > ratios > ROA
44.82179767273545
Annuals > 2 > ratios > FCF
917925
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
93
Annuals > 3 > quarter
2020-05-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-
Annuals > 3 > income Statement > net Income
-
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
2051
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
390433
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
10748
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10748
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-23820
Annuals > 3 > cash Flow > depreciation
355
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-714
Annuals > 3 > cash Flow > capital Expenditures
4265
Annuals > 3 > cash Flow > cash From Investing
214769
Annuals > 3 > cash Flow > cash From Financing
2331006
Annuals > 3 > cash Flow > net Change In Cash
2330292
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-4979
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
45
Valuation > metrics > PE
-0.004825285779413357
Valuation > metrics > PB
7.74012098601264
Valuation > final Score
20
Valuation > verdict
158.0% Overvalued
Profitability > metrics > ROE
-55.994446363936554
Profitability > metrics > ROA
-41.42177412889809
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6028652988266733
Risk > metrics > Interest Coverage
-3.2304609990560404
Risk > final Score
35
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.2521277748158974
Liquidity > metrics > Quick Ratio
2.2521277748158974
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
31.587796421370438
Prev Valuations > 1
42.844494341612666
Prev Valuations > 2
49.82609446316331
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-2
Prev Risks > 1
26
Prev Risks > 2
43
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:23:38.765Z
Earnings History > 0 > period
2025-08-31
Earnings History > 0 > report Date
2025-09-26
Earnings History > 0 > date
2025-08-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.01
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.01
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-05-31
Earnings History > 1 > report Date
2025-05-31
Earnings History > 1 > date
2025-05-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0033
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-02-28
Earnings History > 2 > report Date
2025-04-24
Earnings History > 2 > date
2025-02-28
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0029
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-11-30
Earnings History > 3 > report Date
2025-01-27
Earnings History > 3 > date
2024-11-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.003
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-08-31
Earnings History > 4 > report Date
2024-11-22
Earnings History > 4 > date
2024-08-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0031
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-05-31
Earnings History > 5 > report Date
2024-05-31
Earnings History > 5 > date
2024-05-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.003
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-02-29
Earnings History > 6 > report Date
2024-02-29
Earnings History > 6 > date
2024-02-29
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0031
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-11-30
Earnings History > 7 > report Date
2023-11-30
Earnings History > 7 > date
2023-11-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0088
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-08-31
Earnings History > 8 > report Date
2023-08-31
Earnings History > 8 > date
2023-08-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0113
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-05-31
Earnings History > 9 > report Date
2023-05-31
Earnings History > 9 > date
2023-05-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0133
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-02-28
Earnings History > 10 > report Date
2023-02-28
Earnings History > 10 > date
2023-02-28
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0063
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-11-30
Earnings History > 11 > report Date
2023-01-26
Earnings History > 11 > date
2022-11-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.03
Earnings History > 11 > eps Estimate
-0.01
Earnings History > 11 > eps Difference
-0.02
Earnings History > 11 > surprise Percent
-200
Earnings History > 12 > period
2022-08-31
Earnings History > 12 > report Date
2022-09-28
Earnings History > 12 > date
2022-08-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
-0.01
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-05-31
Earnings History > 13 > report Date
2022-05-31
Earnings History > 13 > date
2022-05-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.0005
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-02-28
Earnings History > 14 > report Date
2022-04-25
Earnings History > 14 > date
2022-02-28
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.01
Earnings History > 14 > eps Estimate
-0.06
Earnings History > 14 > eps Difference
0.05
Earnings History > 14 > surprise Percent
83.3333
Earnings History > 15 > period
2021-11-30
Earnings History > 15 > report Date
2022-01-27
Earnings History > 15 > date
2021-11-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0013
Earnings History > 15 > eps Estimate
-0.01
Earnings History > 15 > eps Difference
0.0087
Earnings History > 15 > surprise Percent
87
Earnings History > 16 > period
2021-08-31
Earnings History > 16 > report Date
2021-10-27
Earnings History > 16 > date
2021-08-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.01
Earnings History > 16 > eps Estimate
-0.01
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-05-31
Earnings History > 17 > report Date
2021-08-31
Earnings History > 17 > date
2021-05-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0106
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-31
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.0008
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0.0008
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-02-28
Earnings History > 19 > report Date
2021-04-29
Earnings History > 19 > date
2021-02-28
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.0008
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-28
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.0471
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0.0471
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-11-30
Earnings History > 21 > report Date
2021-01-28
Earnings History > 21 > date
2020-11-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.0471
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-11-30
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0136
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-08-31
Earnings History > 23 > report Date
2020-10-15
Earnings History > 23 > date
2020-08-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0136
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0136
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2020-06-30
Earnings History > 24 > report Date
2020-08-31
Earnings History > 24 > date
2020-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.0106
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.0106
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2020-05-31
Earnings History > 25 > report Date
2020-07-23
Earnings History > 25 > date
2020-05-31
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0132
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0132
Earnings History > 25 > surprise Percent
-
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX wearable pump for the maintenance of general anesthesia for diagnostic, surgical procedures and pain indications. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson's disease; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APharmaTher CEO Targets 2026 Asset Monetization After Ketamine ANDA Sale and FDA Win The Globe and Mail
Read more →Ketamine-focused company lays out 2026 plan to unlock value from assets Stock Titan
Read more →Showing 2 of 9
(Last Updated 2025-08-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Pharmather Holdings Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-08-31
EPS Actual
-0.01
EPS Estimate
0
EPS Difference
-0.01
Surprise Percent
0%
(Last Updated 2025-08-31)
(Last Updated 2025-08-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-08-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-08-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.